The Global radiation therapy quality assurance (QA) phantoms market is expected to reach a market size of USD 36.4 Million by 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research.

The Quality check and assurance before delivering radiation treatment to a cancer patient is critical in order to maintain the radiation dose as prescribed by the doctor. Some major drivers fueling growth of the global radiation therapy quality assurance (QA) phantoms market include enhancement of patient and machine quality assurance in radiation oncology, rising demand for tissue equivalent phantoms, and increasing number of cancer patients globally. Dosimetry phantoms in radiation therapy treatment plays a vital role in ensuring the accuracy of a planned dose. Quality assurance phantoms are primarily used for calibration and characterization of delivery devices. Apart from that, phantoms are used for verifying distributions of modeled (planned) dose.

The report on the global Radiation Therapy Quality Assurance (QA) Phantoms market provides a panoramic view of the current market scenario and takes into account the impact of the COVID-19 pandemic on the overall market growth and its key segments. The report offers a crystal clear understanding of the fluctuations in the market dynamics and trends during the projected timeline. The report also considers the factors likely to impact the market growth and overall dynamics of the market. The study also assesses the market growsth over the forecast period of 2020-2027, along with a particular focus on the trends, growth opportunities, trends, restraining factors, and limitations.

To know more about the report @ https://www.emergenresearch.co....m/industry-report/ra